Kabir, Eva RahmanBishakha, Adwiza Chakraborty2024-01-022024-01-0220232023-03ID 19146074http://hdl.handle.net/10361/22052Cataloged from PDF version of thesis.Includes bibliographical references (pages 28-34).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.GLP-1 Receptor Agonists (GLP-1 RAs) are a choice of antidiabetic drugs in the management of Type-2 Diabetes Mellitus (T2DM). Currently, there are five classes of GLP-1 RA drugs available in the market, all of which are widely prescribed among T2DM patients worldwide. Despite their efficacy in managing the symptoms of T2DM, there are some unusual side effects like pancreatitis that may occur according to FAERS database while using the drugs. Although, different studies have suggested otherwise. The study that is conducted is based on the post surveillance data retrieved from FAERS database. This study has established that there is a significant association of pancreatitis and GLP-1 RAs for which signal detection was used by using reporting odds ratio (ROR).34 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Type-2 diabetes mellitusGLP-1 receptor agonistsPancreatitisFAERSPharmacovigilanceAntidiabetic drugsAssociation of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS databaseThesis